Literature DB >> 22057233

A novel automated indirect immunofluorescence autoantibody evaluation.

Shaye Kivity1, Boris Gilburd, Nancy Agmon-Levin, Marina Garcia Carrasco, Yaron Tzafrir, Yael Sofer, Matilda Mandel, Thomas Buttner, Dirk Roggenbuck, Marco Matucci-Cerinic, Katalin Danko, Marcos López Hoyos, Yehuda Shoenfeld.   

Abstract

Autoantibodies (AAb), especially antinuclear (ANAs) and anticytoplasmatic antibodies (ACyA), are essential diagnosing markers for several autoimmune diseases. The current gold standard method for ANA detection is manual indirect immunofluorescence (IIF) on human epithelial-2 (HEp-2) cells. However, this technique is cost and time consuming, and characterized by considerable intra- and interlaboratory variability. Thus, an automated IIF-HEp-2 reader has been developed recently. In the current study, we compared the performance of the automated AAb IIF-HEp-2 interpretation to conventional detection methods. Autoantibody detection by IIF on HEp-2 cells was performed in a total of 260 sera of patients, including 34 with systemic lupus erythematosus, 111 with dermatomyositis or polymyositis, 74 with systemic sclerosis, 41 with rare AAb patterns, and 137 healthy individuals. Visual interpretation and routine immunoassays were compared with a novel automated IIF-HEp-2 system using Aklides pattern recognition algorithms. Positive AAbs were detected in 95-100% of rheumatic patients by automated interpretation, in 74-100% with manual reading, and in 64-100% by immunodot assay. Receiver operating characteristic curve analysis of fluorescent intensity revealed a high sensitivity and specificity for automated reading of AAb with an agreement ranging from 90% to 95% between manual and automated interpretation (kappa 0.554-0.69) for systemic sclerosis and myositis, respectively. This study demonstrates a good correlation between manual and automated interpretation of AAb including ANA and ACyA in patients with autoimmune diseases. Full automation of HEp-2 cell assay reading may minimize errors in ANA pattern interpretation and thus help in the standardization of ANA assessment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057233     DOI: 10.1007/s10067-011-1884-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.

Authors:  Daniel H Solomon; Arthur J Kavanaugh; Peter H Schur
Journal:  Arthritis Rheum       Date:  2002-08

2.  [Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses].

Authors:  K Hartung; H-P Seelig
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 3.  Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.

Authors:  A S Wiik
Journal:  Scand J Rheumatol       Date:  2005 Jul-Aug       Impact factor: 3.641

Review 4.  Commercial blot assays in the diagnosis of systemic rheumatic diseases.

Authors:  Anna Ghirardello; Raffaele Bendo; Maria Elisa Rampudda; Nicola Bassi; Sandra Zampieri; Andrea Doria
Journal:  Autoimmun Rev       Date:  2009-02-12       Impact factor: 9.754

5.  European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.

Authors:  A Wiik; R Cervera; M Haass; C Kallenberg; M Khamashta; P L Meroni; J-C Piette; R Schmitt; Y Shoenfeld
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 6.  [Scleroderma associated autoantibodies - clinical and diagnostic relevance].

Authors:  R Mierau; E Genth
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

7.  Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.

Authors:  Kai Grossmann; Dirk Roggenbuck; Christian Schröder; Karsten Conrad; Peter Schierack; Ulrich Sack
Journal:  Cytometry A       Date:  2011-01-03       Impact factor: 4.355

8.  Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.

Authors:  Rajpreet K Arora-Singh; Shervin Assassi; Deborah J del Junco; Frank C Arnett; Marilyn Perry; Uzma Irfan; Roozbeh Sharif; Tony Mattar; Maureen D Mayes
Journal:  J Autoimmun       Date:  2010-03-11       Impact factor: 7.094

Review 9.  Definition of human autoimmunity--autoantibodies versus autoimmune disease.

Authors:  Ana Lleo; Pietro Invernizzi; Bin Gao; Mauro Podda; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-04       Impact factor: 9.754

Review 10.  [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].

Authors:  B Admou; L Essaadouni; S Amal; N Arji; L Chabaa; R El Aouad
Journal:  Ann Biol Clin (Paris)       Date:  2009 May-Jun       Impact factor: 0.459

View more
  27 in total

1.  A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.

Authors:  O Shovman; N Agmon-Levin; B Gilburd; T Martins; A Petzold; T Matthias; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test.

Authors:  M Infantino; F Meacci; V Grossi; M Manfredi; M Benucci; M Merone; P Soda
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.

Authors:  Anne E Tebo
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

Review 4.  Low-cost bioanalysis on paper-based and its hybrid microfluidic platforms.

Authors:  Maowei Dou; Sharma Timilsina Sanjay; Merwan Benhabib; Feng Xu; XiuJun Li
Journal:  Talanta       Date:  2015-05-06       Impact factor: 6.057

Review 5.  Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.

Authors:  Luigi Cinquanta; Nicola Bizzaro; Giampaola Pesce
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

6.  Porcine E. coli: virulence-associated genes, resistance genes and adhesion and probiotic activity tested by a new screening method.

Authors:  Peter Schierack; Stefan Rödiger; Christoph Kuhl; Rico Hiemann; Dirk Roggenbuck; Ganwu Li; Jörg Weinreich; Enrico Berger; Lisa K Nolan; Bryon Nicholson; Antje Römer; Ulrike Frömmel; Lothar H Wieler; Christian Schröder
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

7.  Serum autoantibodies: from identification to clinical relevance.

Authors:  Pietro Invernizzi; Xavier Bossuyt; Dimitrios P Bogdanos
Journal:  Clin Dev Immunol       Date:  2013-03-20

8.  Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells.

Authors:  Jörn Voigt; Christopher Krause; Edda Rohwäder; Sandra Saschenbrecker; Melanie Hahn; Maick Danckwardt; Christian Feirer; Konstantin Ens; Kai Fechner; Erhardt Barth; Thomas Martinetz; Winfried Stöcker
Journal:  Clin Dev Immunol       Date:  2012-11-11

9.  Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis.

Authors:  Ilka Knütter; Rico Hiemann; Therese Brumma; Thomas Büttner; Kai Großmann; Marco Cusini; Francesca Pregnolato; Maria Orietta Borghi; Ursula Anderer; Karsten Conrad; Dirk Reinhold; Dirk Roggenbuck; Elena Csernok
Journal:  Arthritis Res Ther       Date:  2012-12-14       Impact factor: 5.156

Review 10.  New platform technology for comprehensive serological diagnostics of autoimmune diseases.

Authors:  Annika Willitzki; Rico Hiemann; Vanessa Peters; Ulrich Sack; Peter Schierack; Stefan Rödiger; Ursula Anderer; Karsten Conrad; Dimitrios P Bogdanos; Dirk Reinhold; Dirk Roggenbuck
Journal:  Clin Dev Immunol       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.